Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$5.47 - $10.14
Next Earnings Date
Apr 30 2025
Next Earnings Date
Apr 30 2025
Last Price
Market Cap | $1.02B |
EV | $940.20M |
Shares Outstanding | 148.95M |
Beta | 1.74 |
Analyst Rating | BUY |
Analyst Target Price | $13.00 |
P/E 2025E | 25.87x |
P/Revenue 2025E | 2.73x |
Revenue | 10.50% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 9.60% |
EPS | 7.70% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 82.46% |
Net Profit Margin 2025E | 10.69% |
ROE 2025E | - |
ROCE 2024 | 25.01% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
MiMedx Group, Inc.
MDXG
Sector
Healthcare
Industry
Biotechnology
CEO
Capper, Joseph
Employees
837
Website
www.mimedx.comIPO Date
2008-02-12
Headquarters
1775 West Oak Commons Court, NE, Marietta, Georgia, 30062, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved